The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

Detalles Bibliográficos
Autores principales: Pandey, Rajshree, Ollendorf, Daniel A, Fazioli, Katherine, Bloudek, Lisa, Carlson, Josh J, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391273/
https://www.ncbi.nlm.nih.gov/pubmed/33645245
http://dx.doi.org/10.18553/jmcp.2021.27.3.405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391273/
https://www.ncbi.nlm.nih.gov/pubmed/33645245
http://dx.doi.org/10.18553/jmcp.2021.27.3.405

Ejemplares similares